Lucide Ledger

A filing-first public record from Lucide House.

Issue 000 | U.S. Pilot | US

APRE

Aprea Therapeutics, Inc.

Passing Verified 10-Q | 2026-05-13 Filing currency: USD
Open Filing Back to Register
Margin of Safety 78.5%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
47,245,440USD
Total Liabilities
6,024,007USD
NCAV
41,221,433USD
Cash
46,466,202USD
NCAV per share
needs review
Evidence
7 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one APRE, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
Revenue n/a n/a n/a n/a n/a n/a n/a
Operating Income -13,233,836 -14,319,655 -15,471,963 -113,392,228 -37,446,353 n/a n/a
Net Income -12,599,569 -12,958,711 -14,286,756 -112,662,027 -37,127,303 -53,478,812 -28,059,807
Cash From Operations -12,894,439 -13,556,718 -12,177,608 -25,011,136 -37,686,179 -41,802,672 -26,708,707
Capex n/a -15,478 -93,093 n/a n/a -25,709 -30,901
Free Cash Flow n/a -13,572,196 -12,270,701 n/a n/a -41,828,381 -26,739,608
Cash And Equivalents 14,599,347 22,849,885 21,606,820 28,786,647 53,076,052 89,017,686 130,088,869
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 15,561,246 23,576,139 22,521,095 30,153,506 56,584,410 92,416,705 133,044,747
Total Assets 15,933,401 23,979,493 22,650,174 30,155,827 56,823,463 92,805,219 133,607,885
Total Current Liabilities 2,764,358 3,360,975 4,385,605 3,201,086 7,316,499 15,331,165 9,061,734
Total Liabilities n/a n/a n/a 3,201,086 7,316,499 15,410,012 9,364,355
Shareholders Equity 12,441,682 19,307,455 16,953,506 25,643,678 49,506,964 77,395,207 124,243,530
Shares Outstanding 8,192,538 5,481,055 3,736,673 2,655,269 21,859,413 21,186,827 21,022,752
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 6,538,722 5,509,921 3,617,607 1,657,055 21,286,547 21,133,651 6,002,486
Weighted Avg Shares Basic 6,538,722 5,509,921 3,617,607 1,657,055 21,286,547 21,133,651 6,002,486
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -3,430,412 -2,643,093 -3,117,388 -3,387,773 -4,085,582 -3,226,045 -4,097,016 -3,846,924 -3,149,670 -3,674,929 -3,522,850 -3,651,681 -4,622,503 n/a -4,200,194 n/a n/a n/a n/a n/a
Net Income -3,287,917 -2,455,630 -2,972,410 -3,238,870 -3,932,659 -2,894,799 -3,783,769 -3,470,052 -2,810,091 -3,443,254 -3,204,515 -3,259,097 -4,379,890 -2,442,142 -4,024,718 -98,258,474 -7,936,693 -7,755,184 -9,452,351 -10,251,013
Cash From Operations -2,756,726 -2,961,292 -3,171,230 -3,130,754 -3,631,163 -3,510,904 -2,468,302 -3,641,621 -3,935,891 -3,739,658 -2,241,965 -3,216,904 -2,979,081 -4,020,512 -6,592,682 -8,902,613 -5,495,329 -10,178,787 -8,233,403 -7,751,883
Capex n/a n/a n/a n/a n/a 0 0 -7,500 -7,978 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a -3,510,904 -2,468,302 -3,649,121 -3,943,869 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents 46,466,202 14,599,347 13,718,052 16,532,199 19,275,721 22,849,885 26,249,625 28,694,694 32,369,973 21,606,820 25,353,513 27,685,131 30,995,714 28,786,647 33,112,601 39,062,415 47,651,774 53,076,052 61,428,404 69,803,845
Total Current Assets 47,245,440 15,561,246 13,943,988 16,927,210 19,834,410 23,576,139 26,483,820 29,559,786 33,068,837 22,521,095 25,639,776 28,638,801 32,018,517 30,153,506 33,473,779 40,463,252 50,044,870 56,584,410 62,179,333 71,298,298
Total Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3,950,821 4,227,388 3,201,086 3,998,139 7,684,197 6,748,183 7,316,499 9,069,589 10,598,061
Shares Outstanding 11,982,776 8,192,538 5,979,292 5,752,175 5,512,656 5,481,055 5,434,903 5,430,215 5,430,215 3,736,673 3,736,673 3,731,571 3,731,571 2,655,269 52,237,885 23,401,846 21,974,302 21,859,413 21,360,140 21,186,827
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 14,685,448 6,538,722 6,372,938 6,083,329 5,993,866 5,509,921 5,939,755 5,937,291 4,198,326 3,617,607 3,731,571 3,731,571 3,260,484 1,657,055 34,655,750 22,661,835 21,901,531 21,286,547 21,231,584 21,186,827
Weighted Avg Shares Basic 14,685,448 6,538,722 6,372,938 6,083,329 5,993,866 5,509,921 5,939,755 5,937,291 4,198,326 3,617,607 3,735,176 3,731,571 3,260,484 1,657,055 34,655,750 22,661,835 21,901,531 21,286,547 21,231,584 21,186,827
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 47,245,440USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001781983/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001781983\companyfacts.json
Total Liabilities n/a derived 2026-03-31 n/a n/a
Cash 46,466,202USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 sec/companyfacts/cik=0001781983/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001781983\companyfacts.json
Shares Outstanding 11,982,776 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001781983/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001781983\companyfacts.json
NCAV n/a derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share n/a derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 78.5% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV could not be calculated because one or more inputs are missing.

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001781983
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001781983\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001781983\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
22
Imported At
2026-07-04T23:04:24+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001104659-26-059743
CIK
0001781983
Mary Filing Date
2026-05-13
Filing Currency
USD
Internal Discount
78.5%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001104659-26-059743; mary_cik=0001781983; gnni_supporting_filing_date=2026-05-13; internal_discount=0.784597; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive